Skip to main content

Table 2 Inclusion/Exclusion criteria

From: Protocol for the SEHNeCa randomised clinical trial assesing Supervised Exercise for Head and Neck Cancer patients

Inclusion criteria

Exclusion criteria

Diagnosis of carcinoma of the larynx (except T1-T2 N0 of the glottis), pharynx, oral cavity, salivary gland, paranasal sinuses, or cervical metastasis of unknown origin in stages I-II-III-IVa-IVb

Decompensated heart disease, uncontrolled hypertension (SBP > 200 or DAT > 110), heart failure (NYHA > I), or constrictive pericarditis

Radiotherapy (with or without concomitant chemotherapy) preceded or not by surgical treatment and performed with radical intent

Medical contraindication against exercise (such as bone fractures, tendon ruptures, spondylolisthesis > 25% with neurological compromise, rhabdomyolysis, herniated disc in the spine with neurological symptoms, cardiovascular comorbidities such as unstable angina, current myocarditis or thrombophlebitis); Neutropenia (< 500 mm3), severe anaemia (Hb < 8.0 g/dl), platelet count < 50.000 microL

 > 18 years

Radiotherapy with palliative intent

BMI > 18.5

Pregnancy

ECOG 0–1 or Karnofsky Index ≥ 80%

Regular physical activity (150 min/week of moderate activity or 75 min/week of vigorous activity, including two or more weekly strength training sessions), as measured by the PVS questionnaire

Signed consent form

Carcinoma of the glottis (T1-T2, N0)

  1. T(1–2) Tumour (TNM classification), N(0) Node (TNM classification), SBP systolic blood pressure, DAT Diastolic blood pressure, NYHA New York Heart Association, Hb Haemoglobin, BMI Body Mass Index, ECOG Eastern Cooperative Oncology Group, PVS Prescribe Healthy Life